Cargando…

Impact of local treatment on survival from hematological malignancies causing spinal cord compression

BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghedira, Hela, Radhouane, Khaled, Mezni, Essia, Yahiaoui, Safia, Stambouli, Hela, Yedeas, Mohamed Dehmani, Belaid, Asma, Ammar, Chiraz, Kacem, Karima, Zriba, Samy, Msadek, Fehmi, Yedeas, Mondher, Harbaoui, Ahmed, Chkili, Ridha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656002/
https://www.ncbi.nlm.nih.gov/pubmed/33194285
http://dx.doi.org/10.25259/SNI_592_2020
_version_ 1783608286604427264
author Ghedira, Hela
Radhouane, Khaled
Mezni, Essia
Yahiaoui, Safia
Stambouli, Hela
Yedeas, Mohamed Dehmani
Belaid, Asma
Ammar, Chiraz
Kacem, Karima
Zriba, Samy
Msadek, Fehmi
Yedeas, Mondher
Harbaoui, Ahmed
Chkili, Ridha
author_facet Ghedira, Hela
Radhouane, Khaled
Mezni, Essia
Yahiaoui, Safia
Stambouli, Hela
Yedeas, Mohamed Dehmani
Belaid, Asma
Ammar, Chiraz
Kacem, Karima
Zriba, Samy
Msadek, Fehmi
Yedeas, Mondher
Harbaoui, Ahmed
Chkili, Ridha
author_sort Ghedira, Hela
collection PubMed
description BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma (28%), and indolent lymphoma (9%), resulting in spinal cord compression (2004 and 2016). Patients averaged 57 years of age and presented with the indolent onset of spinal cord compression (91% of cases) resulting mostly in motor deficits (69%). RESULTS: Local treatment modalities included radiotherapy (RT) (28%) alone, decompressive surgery (28%) alone, or decompressive surgery with consolidation RT (40%). The 1-year overall survival was 70%, and the progression-free survival frequency was 62%. CONCLUSION: This study highlighted the importance of standardizing the indications for RT alone versus RT with surgery depending on the patient’s underlying pathological diagnosis, neurological deficits, and radiological findings.
format Online
Article
Text
id pubmed-7656002
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-76560022020-11-13 Impact of local treatment on survival from hematological malignancies causing spinal cord compression Ghedira, Hela Radhouane, Khaled Mezni, Essia Yahiaoui, Safia Stambouli, Hela Yedeas, Mohamed Dehmani Belaid, Asma Ammar, Chiraz Kacem, Karima Zriba, Samy Msadek, Fehmi Yedeas, Mondher Harbaoui, Ahmed Chkili, Ridha Surg Neurol Int Original Article BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma (28%), and indolent lymphoma (9%), resulting in spinal cord compression (2004 and 2016). Patients averaged 57 years of age and presented with the indolent onset of spinal cord compression (91% of cases) resulting mostly in motor deficits (69%). RESULTS: Local treatment modalities included radiotherapy (RT) (28%) alone, decompressive surgery (28%) alone, or decompressive surgery with consolidation RT (40%). The 1-year overall survival was 70%, and the progression-free survival frequency was 62%. CONCLUSION: This study highlighted the importance of standardizing the indications for RT alone versus RT with surgery depending on the patient’s underlying pathological diagnosis, neurological deficits, and radiological findings. Scientific Scholar 2020-10-21 /pmc/articles/PMC7656002/ /pubmed/33194285 http://dx.doi.org/10.25259/SNI_592_2020 Text en Copyright: © 2020 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ghedira, Hela
Radhouane, Khaled
Mezni, Essia
Yahiaoui, Safia
Stambouli, Hela
Yedeas, Mohamed Dehmani
Belaid, Asma
Ammar, Chiraz
Kacem, Karima
Zriba, Samy
Msadek, Fehmi
Yedeas, Mondher
Harbaoui, Ahmed
Chkili, Ridha
Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title_full Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title_fullStr Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title_full_unstemmed Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title_short Impact of local treatment on survival from hematological malignancies causing spinal cord compression
title_sort impact of local treatment on survival from hematological malignancies causing spinal cord compression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656002/
https://www.ncbi.nlm.nih.gov/pubmed/33194285
http://dx.doi.org/10.25259/SNI_592_2020
work_keys_str_mv AT ghedirahela impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT radhouanekhaled impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT mezniessia impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT yahiaouisafia impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT stamboulihela impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT yedeasmohameddehmani impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT belaidasma impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT ammarchiraz impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT kacemkarima impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT zribasamy impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT msadekfehmi impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT yedeasmondher impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT harbaouiahmed impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression
AT chkiliridha impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression